Depomed Inc (NASDAQ:DEPO)
| 5.48 Data as of May 17 |  +0.08 / +1.48%Today’s Change | 4.75 Today|||52-Week Range 7.15 | -11.47% Year-to-Date |
Latest DEPO News | Press Releases
| The Gory Details on DepoMed's Double Miss May 09 / MotleyFool.com | DepoMed, in the Spotlight Soon May 06 / MotleyFool.com |
Today’s Trading
| Previous close | 5.40 |
| Today’s open | 5.41 |
| Day’s range | 5.31 - 5.51 |
| Volume | 674,139 |
| Average volume (3 months) | 551,522 |
| Market cap | $309.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -142.06% |
| Earnings growth (this year) | +80.66% |
| Earnings growth (next 5 years) | +72.00% |
| Revenue growth (last year) | -31.70% |
| P/E ratio | NM |
| Price/Sales | 3.81 |
| Price/Book | 3.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| UNISUnilife Corp | 0.00 | 0.00% |
| ELOSSyneron Medical Ltd | +0.11 | +1.25% |
| ANGOAngioDynamics Inc | 0.00 | 0.00% |
| OSUROraSure Technologies... | +0.01 | +0.23% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $90.8M |
| Annual profit (last year) | -$29.8M |
| Net profit margin | -32.79% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director James A. Schoeneck |
CFO, Senior VP & Head-Investor Relations August J. Moretti |
Corporate headquarters Menlo Park, California |
Forecasts
